99% up, USP34，GMP, DMF 6-Benzofurancarboxylic Acid 77095-51-3

Name: 99% up, USP34，GMP, DMF 6-Benzofurancarboxylic Acid 77095-51-3
Availability: 99-up-usp34-gmp-dmf-6-benzofurancarboxyl-277701.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:99% up, USP34，GMP, DMF 6-Benzofurancarboxylic Acid 77095-51-3
CAS No.:77095-51-3
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co.Ltd.

Send Inquiry

Favorites

Similar Products

3-methylidenecyclobutane-1-carboxylic acid

Ephedrine Hcl

Acesulfame Potassium

3,6-dibromo-2-fluorobenzaldehyde

Relugolix

Tirzepatide

Trimetinib intermediate

PVP K17

Florfenicol

2-([1,1'-biphenyl]-4-yl)-4-(4-(4-chloronaphthalen-1-yl)phenyl)-6-phenyl-1,3,5-triazine

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

Product Information

Product name	6-Benzofurancarboxylic acid
Systematic name	1-benzofuran-6-carboxylic acid; Benzofuran-6-carboxylic acid; LIFI-009; Lifitegrast intermediate
CAS No.	77095-51-3
Molecular Formula	C9H6O3
Molecular Weight	162.145
Quality Standard	99% up
Appearance	White powder

Usage

6-Benzofurancarboxylic acid is one of the key intermediates of Lifitegrast.

Function of Lifitegrast

Lifitegrast is a leukocyte function antigen 1 antagonist used in the treatment of dry eye. Lifitegras can bind to leukocyte functional antigen 1 (LFA-1), preventing the binding of LFA-1 to its cognate ligand intercellular adhesion molecule-1 (ICAM-1). ICAM-1 is overexpressed in the corneal Chemicalbook membrane and conjunctival tissues of patients with dry eye, and LFA-1 binds to ICAM-1 to promote the formation of immune synapses, leading to activation of T cells and migration to target tissues. In vitro studies have shown that Lifitegrast can inhibit T cell adhesion to ICAM-1 and also inhibit the secretion of inflammatory cytokines in human peripheral blood mononuclear cells.

Send your message to this supplier

From:
To:
Sinoway Industrial Co.Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Other Products from this supplier
More>>

NICOTINAMIDE MONONUCLEOTIDE (NMN) 1094-61-7

STEVIA LEAF EXTRACT 57817-89-7

L-GLUTATHIONE REDUCED (GSH) 70-18-8

NICOTINAMIDE ADENINE DINUCLEOTIDE 58-84-9

ALPHA GPC 28319-77-9

PALMITOYLETHANOLAMIDE (PEA) 544-31-0

PTEROSTILBENE 537-42-8

VONOPRAZAN FUMARATE 1260141-27-2

AZILSARTAN 147403-03-0

LOSARTAN POTASSIUM 124750-99-8

99% up, USP34，GMP, DMF 6-Benzofurancarboxylic Acid 77095-51-3

Product Information

Product name

6-Benzofurancarboxylic acid

Systematic name

1-benzofuran-6-carboxylic acid; Benzofuran-6-carboxylic acid; LIFI-009; Lifitegrast intermediate

CAS No.

77095-51-3

Molecular Formula

C9H6O3

Molecular Weight

162.145

Quality Standard

99% up

Appearance

White powder

Usage

6-Benzofurancarboxylic acid is one of the key intermediates of Lifitegrast.

Function of Lifitegrast

Other Products from this supplierMore>>

Other Products from this supplier
More>>